This study compared tigecycline with a current empiric combination treatment for intra-abdominal infections comprised of Primaxin, a common treatment for such illnesses. |
At present, only two antibiotic subclasses are still available to treat XDR infections, polymyxins and tigecycline. |
All 3 MDR isolates from urine were susceptible to tigecycline, 2 to ciprofloxacin and 1 each to ofloxacin or rifampicin. |
However, CRE isolate data did not contain information on susceptibility to other CRE treatment options, including colistin, tigecycline, polymyxin B, and fosfomycin. |